Plant Advanced Technologies SA - Asset Resilience Ratio

Latest as of December 2022: 30.95%

Plant Advanced Technologies SA (ALPAT) has an Asset Resilience Ratio of 30.95% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check ALPAT strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

€5.29 Million
≈ $6.18 Million USD Cash + Short-term Investments

Total Assets

€17.08 Million
≈ $19.97 Million USD All company assets

Resilience Assessment

Very High
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2022)

This chart shows how Plant Advanced Technologies SA's Asset Resilience Ratio has changed over time. See ALPAT net asset quality score to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Plant Advanced Technologies SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Plant Advanced Technologies SA market cap and net worth.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents €0.00 0%
Short-term Investments €5.29 Million 30.95%
Total Liquid Assets €5.29 Million 30.95%

Asset Resilience Insights

  • Very High Liquidity: Plant Advanced Technologies SA maintains exceptional liquid asset reserves at 30.95% of total assets.
  • This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
  • The company has significant short-term investments, indicating active treasury management.

Plant Advanced Technologies SA Industry Peers by Asset Resilience Ratio

Compare Plant Advanced Technologies SA's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
CSL Ltd
AU:CSL
Biotechnology 0.41%
BB Biotech AG
SW:BION
Biotechnology 0.05%
Concord Biotech Limited
NSE:CONCORDBIO
Biotechnology 18.00%
Pharming Group NV
AS:PHARM
Biotechnology 7.13%
Innovita Biological Technology Co. Ltd. A
SHG:688253
Biotechnology 65.12%
Wuhan Keqian Biology Co Ltd
SHG:688526
Biotechnology 19.42%
Clarity Pharmaceuticals Ltd
AU:CU6
Biotechnology 73.99%
Yantai Zhenghai Bio-Tech Co Ltd
SHE:300653
Biotechnology 56.48%

Annual Asset Resilience Ratio for Plant Advanced Technologies SA (2009–2022)

The table below shows the annual Asset Resilience Ratio data for Plant Advanced Technologies SA.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2022-12-31 30.95% €5.29 Million
≈ $6.18 Million
€17.08 Million
≈ $19.97 Million
-0.10pp
2021-12-31 31.06% €5.31 Million
≈ $6.21 Million
€17.11 Million
≈ $20.00 Million
+0.52pp
2020-12-31 30.53% €5.27 Million
≈ $6.16 Million
€17.27 Million
≈ $20.19 Million
+40.56pp
2019-12-31 -10.02% €-1.39 Million
≈ $-1.63 Million
€13.89 Million
≈ $16.24 Million
-10.06pp
2013-12-31 0.04% €1.68K
≈ $1.96K
€4.26 Million
≈ $4.98 Million
-0.01pp
2012-12-31 0.05% €1.68K
≈ $1.96K
€3.54 Million
≈ $4.14 Million
-0.01pp
2011-12-31 0.06% €1.68K
≈ $1.96K
€2.88 Million
≈ $3.37 Million
+0.01pp
2010-12-31 0.05% €1.68K
≈ $1.96K
€3.22 Million
≈ $3.76 Million
+0.04pp
2009-12-31 0.01% €80.00
≈ $93.53
€1.02 Million
≈ $1.19 Million
--
pp = percentage points

About Plant Advanced Technologies SA

PA:ALPAT France Biotechnology
Market Cap
$7.11 Million
€6.08 Million EUR
Market Cap Rank
#27813 Global
#496 in France
Share Price
€5.40
Change (1 day)
-10.00%
52-Week Range
€5.40 - €10.20
All Time High
€28.20
About

Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution to produce your exclusive, personalized Exudactive; and PAT Target Binding, which finds the ligands that bind to the protein targets of interest, such as enzymes. … Read more